top of page
32200c5c-7c4c-438f-a9df-3119a2398bf2.png
Autchmaber1.png
ai-cvd.png
AI-CVD Summary
Coronary Calcification
816_aicvd (8)_4_edited.jpg
‌ Aortic Calcification
ٍEpicardial Fat _edited.jpg
Epicardial Fat
816_aicvd (8)_5_edited.jpg
Cardiac Chambers
816_aicvd (8)_7_edited.jpg
Aorta & PA Size
816_aicvd (8)_10_edited.jpg
Lung LAI
816_aicvd (8)_9_edited.jpg
Lung HAI
816_aicvd (8)_11_edited.jpg
Liver Fat
816_aicvd (8)_12_edited.jpg
Muscle & Visceral Fat
816_aicvd (8)_13_edited.jpg
Bone Density
Liver Attenuation.png
Cardiac Chambers Volumetry.png
Bone Mineral Density (BMD) .png
AI-CVD--.png
Lung Density Report- High Attenuation Index.png
Liver Attenuation.png
Cardiac Chambers Volumetry.png
coronaryArteryCalcification.png
Thoracic Aorta and Pulmonary Artery Sizing .png
Aortic Wall Aortic and Mitral Valve Report.png
Liver Attenuation.png
Frame 1000008569.png
Frame 1000008568.png
Learn More AI-CVD >

Congratulations to
Professor Anthony Reeves

who Presented the Multi-Center Collaborative Research on Screening for High-Risk Afib and Heart Failure Patients by Measuring Cardiac Chambers Volume in Non-Contrast Chest CT Scans (Calcium Score and Lung Cancer Screening) using HeartLung's Innovative AI-Enabled Solution: AutoChamberTM

Congratulations to
Professor Anthony Reeves

who Presented the Multi-Center Collaborative Research on Screening for High-Risk Afib and Heart Failure Patients by Measuring Cardiac Chambers Volume in Non-Contrast Chest CT Scans (Calcium Score and Lung Cancer Screening) using HeartLung's Innovative AI-Enabled Solution: AutoChamberTM

up for a free demonstration and see how AutoBMD™ can add value to your practice.

bifold inside pg 2.png
bifold inside pg 1.png
Yank.jpg
“Providing high-risk people a DEXA equivalent FDA-approved BMD report with no additional radiation is an obvious benefit.”

Dr. David Yankelevitz

Professor of Radiology at Mount Sinai Hospital, NY. Lung Cancer Biopsy ACR Guidelines Committee Member

Morteza-Naghavi.jpg
“HeartLung is focused on AI-enabled early detection of subclinical preventable diseases such as coronary artery disease, lung cancer, osteoporosis, and fatty liver disease using CT scans which are available worldwide. AutoBMD™ is the first low-hanging fruit that we aimed and received FDA approval for. AutoCAC™ AutoLung™ and more will follow.”

Dr. Morteza Naghavi

Physician Inventor and Founder of HeartLung Technologies
President of SHAPE (Society for Heart Attack Prevention and Eradication) 

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

contact@heartlung.ai

(310) 510-6004

Privacy Policy

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png
autoliver patent.png

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page